Ziliang Kang

Brigham and Women's Hospital

Papers

2

Total Citations

129

H-Index

2

About

Ziliang Kang is a pioneering researcher in bioinspired robotics and drug delivery, whose work bridges mechanical engineering and gastrointestinal medicine. His most impactful contribution is the development of **RoboCap**, a robotic mucus-clearing capsule that dramatically enhances oral drug delivery for proteins and biologics—traditionally limited by the harsh gastrointestinal environment and the mucus barrier. This innovation, published in 2022 and cited over 114 times, represents a paradigm shift in non-invasive therapeutics, potentially replacing painful injections for conditions like diabetes and autoimmune disorders. Kang’s research focuses on **bioadhesion**, **soft robotics**, and **gastrointestinal biomechanics**, with a recent 2025 paper introducing mechanical underwater adhesive devices for soft, dynamic substrates—a breakthrough with applications in surgical adhesives, marine robotics, and wearable sensors. By mimicking natural adhesion mechanisms, his work addresses long-standing challenges in wet, fluctuating environments. Kang’s achievements have earned him recognition as a rising leader in translational bioengineering, with his RoboCap technology hailed as a transformative platform for oral biologics. His interdisciplinary approach continues to inspire new frontiers in drug delivery and soft matter engineering.

Research Focus

Key Achievements

2
H-Index
2
Papers
129
Total Citations
65
Avg Citations/Paper
🏆 Most Cited Paper
RoboCap: Robotic mucus-clearing capsule for enhanced drug delivery in the gastrointestinal tract
114 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 35
🏛 Institutions: Brigham and Women's Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago